HUDDINGE, Sweden, Jan. 19, 2023 /PRNewswire/ — XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr. Hovstadius will be a member of the company’s management team. Dr. Johan Aschan who retires from…
XNK Therapeutics appoints Dr. Peter Hovstadius as CMO
Technology and Entertainment Magazine
Contact us
renewsindustry@gmail.com
+92 318 3083960